About the OSRA


Committee Meeting Minutes ('03 - '04)



Join the OSRA


National Society for Risk Analysis

Welcome to the Ohio Chapter of the
Society for Risk Analysis (OSRA).

News and Events:

Spring Symposium (July 29) - updated 7/21/03
SRA National Meeting (December 7-10)
TCE Peer Consultation (Fall 2003 - date forthcoming)
OSRA Membership Meeting (November/December 2003 - date forthcoming)
OVSOT Annual Meeting (November 7, 2003)

Spring Symposium:

Spring Symposium "Risk Analysis in the Age of Terrorism", July 29, 2003. This symposium will have topics covering chemical, microbiological and radiological exposures, in settings including the Gulf War theater and the former World Trade Center. Speakers from federal agencies as well as noted anti-terrorism expert, Dr. Doug Rokke, will be on hand to address this highly important topic. We hope you will all come out and attend. See our symposium page for more information.

The meeting will be held at the U.S EPA facility in Cincinnati. The EPA bldg is located at the intersection of Vine Street and Martin Luther King Drive, directly across from the University of Cincinnati campus. The street address is 26 West Martin Luther King Drive, Cincinnati, OH 45268. Register for the symposium here or by sending an Email to OSRA President Dr. Ken Poirier. There is no registration fee.

Photo ID Required for Symposium Admission

EPA guards will not admit visitors without an authorized and proper government-issued piece of identification with photo. In addition, visitors parking on site at EPA must register their
vehicle, with license number, on the guest log at the front guard desk.

return to the top

Society for Risk Analysis Annual Meeting:

Society for Risk Analysis Annual Meeting, December 7-10. 2003. The Annual Meeting will be held in Baltimore this year. This year's theme is "Bridging Risk Divides". Check out the SRA web site events page for more information.

return to the top

TCE Peer Consultation:

Trichloroethylene (TCE) Peer Consultation, Fall 2003. Toxicology Excellence for Risk Assessment (TERA) announces the initiation of a peer consultation process on risk assessment issues for trichloroethylene (TCE) at the request of the United States Air Force. The intent of TERA's process is to assist in the protection of the public's health from exposure to this chemical by providing an open and transparent discussion of key scientific issues. This discussion will occur during a scientific meeting, open to the public, conducted in the fall of 2003.

The meeting will be structured in a way to encourage scientific interchange among interested stakeholders and issue experts. The process will allow all parties with an interest in TCE risk assessment to benefit from the proceedings by leveraging the meeting results for the development or refinement of other ongoing TCE risk assessment activities. TERA is currently planning the details of this process, which will be posted on our website as they become available. If you are interested in participating, please contact Dr. Andrew Maier.

return to the top

OSRA Annual Membership Meeting:

OSRA Annual Membership Meeting. Check back later for details on the date and location of our annual membership meeting. Typically, we've scheduled this meeting to fall either before or after the annual SRA meeting.

return to the top

OVSOT Annual Meeting:

The annual OVSOT meeting will be held on November 7, 2003 at the Andrew W. Breidenbach Environmental Research Center in Cincinnati, OH. The next meeting will focus on the issues surrounding genetic variation in the response to toxicants. There will be 3 speakers with ~45 minutes each with talks addressing on various areas associated with this growing field.

Confirmed speakers are:

  • George Leikauf, U of Cincinnati; genetics/genomics and its application to environmental contaminant concerns.
  • David Hein, U of Louisville; benchtop research investigating the impact of genetic variants/polymorphisms on determinants of toxicity.
  • Harvey Clewell, Environ Corporation, Ruston, LA; physiologically based pharmacokinetics (PBPK) modeling, genetic variation and risk assessment.

Additional information is available in the OVSOT Spring 2003 Newsletter.

return to the top

Page Updated on 7/21/03. Questions or comments? Contact the Webmaster.